Inoviq -Model hTERT -Immunocytochemistry (ICC) Test Assay
The hTERT ICC assay is an immunocytochemistry test that is used as an adjunct to urine cytology.
The product, anti-hTERT antibody (SCD-A7), is:
- An antibody targeted against the hTERT, the protein component of the telomerase complex
- Listed with the FDA as a Class I medical device in the USA, with existing reimbursement in that market
- Anti-hTERT Antibody (SCD-A7) Part Number 01-5002 (SDS)
The EXO-NET matrix has the following features that make it a unique universal technology to facilitate the development of a range of exosome-based liquid biopsy applications:
Customizable
Customizable for use with any sample: serum, plasma, whole blood, saliva, urine and cell culture medium.
Highly specific to the target
Low non-specific binding + Enhanced signal-to-noise
Adaptable
Adaptable to most existing detection technologies: potential for integration with emerging analytical and diagnostic technologies (PCR, ELISA, Flow cytometry, etc.)
Rapid
Time to capture exosomes for downstream analysis is < 15 mins
Demonstrated sensitivity
Up to 1000x improved detection sensitivity over competitors
Technologically Advanced
Combines two separation technologies: size exclusion and affinity binding for improved yield
Scalable
Can be applied to mass screening strategies
Superior Performance
EXO-NET outperforms other exosome capture methods and technologies.